Ancora Advisors, LLC Astrazeneca PLC Transaction History
Ancora Advisors, LLC
- $4.51 Billion
- Q3 2025
A detailed history of Ancora Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Ancora Advisors, LLC holds 1,233 shares of AZN stock, worth $110,230. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,233
Previous 1,196
3.09%
Holding current value
$110,230
Previous $83,000
13.25%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AZN
# of Institutions
1,507Shares Held
501MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...